Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06033924 · ClinicalTrials.gov registry record · NA
Telehealth Delivered Home-based Walking for Vets With Peripheral Artery Disease
A NA study of Peripheral Artery Disease, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- NA
- Development phase
- 225
- Enrollment target
- 3
- Study locations
NCT06033924 is a NA study of Peripheral Artery Disease that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 225 participants, above the 122-participant average among 50 other Peripheral Artery Disease trials with a reported enrollment target (84% higher). The trial reports 3 study locations across 3 states.
The verdict
NCT06033924, a NA study of Peripheral Artery Disease, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- NA
- Development phase
- 225 participants
- Enrollment target
- 3
- Study locations
Study Summary
Walking is beneficial for adults with peripheral arterial disease. Benefits include the ability to walk for longer periods and general well being (quality of life). This study will look at two types of delivery methods for a home-based walking program. The walking program includes step count goals, information on healthy walking and motivational messages. The two delivery methods include a web-based delivery and an telehealth delivery. Participants are randomized to either one of the delivery methods or usual care. After 12 weeks participants in the web based or telehealth based groups maybe re-randomized to receive a combination of both web-based and telehealth for a second 12 week period. After 24 weeks, everyone is followed for an additional 12 weeks, so the total time a participant is in the study is 36 weeks. At baseline, 12, 24 and 36 weeks the investigators ask participant to walk (slowly) on a treadmill, perform a six-minute walk test, and several questionnaires on quality of life. Vouchers are provided at each study visit. All participants who complete the study also keep their pedometer.
Conditions Studied
Interventions
- BEHAVIORAL Walking Program: Internet-based
- BEHAVIORAL Walking Program: Telehealth-based
Study Locations (3)
Alabama
- Birmingham VA Medical Center, Birmingham, AL - Birmingham
California
- VA Palo Alto Health Care System, Palo Alto, CA - Palo Alto
Colorado
- Rocky Mountain Regional VA Medical Center, Aurora, CO - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2024-07-01 |
| Est. Completion | 2027-10-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06033924
The ClinicalTrials.gov registry entry for NCT06033924 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 225 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 122-participant average among 50 other Peripheral Artery Disease trials with a reported enrollment target (84% higher). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Peripheral Artery Disease appearing as the primary indexed condition, and to 2 interventions - of which Walking Program: Internet-based is the first listed.
NCT06033924 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Alabama, California, Colorado.
Frequently Asked Questions
What is clinical trial NCT06033924 about?
NCT06033924 is a clinical study titled "Telehealth Delivered Home-based Walking for Vets With Peripheral Artery Disease". Walking is beneficial for adults with peripheral arterial disease. Benefits include the ability to walk for longer periods and general well being (quality of life). This study will look at two types of delivery methods for a home-based walking program. The walking program includes step count goals, ...
What is the current status of trial NCT06033924?
This trial is currently recruiting. It is a NA study. The enrollment target is 225 participants. The study started on 2024-07-01. Estimated completion is 2027-10-29.
What conditions does trial NCT06033924 study?
This clinical trial studies the following conditions: Peripheral Artery Disease.
What interventions are being tested in trial NCT06033924?
The interventions under investigation include: Walking Program: Internet-based (BEHAVIORAL), Walking Program: Telehealth-based (BEHAVIORAL).
Who is sponsoring clinical trial NCT06033924?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06033924 being conducted?
This trial has 3 study locations across Alabama, California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effects of a Novel, Non-ischemic and Pain-free Exercise Intervention in Peripheral Artery Disease
RECRUITING · NA
-
BEETroot Juice to Reverse Functional Impairment in PAD
RECRUITING · NA
-
The THOR IDE Study
RECRUITING · NA
-
Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy
RECRUITING · NA
-
Leg Heat Therapy in Peripheral Artery Disease
RECRUITING · NA
-
Oxygen-guided Supervised Exercise Therapy
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.